Briumvi

This medication is taken by intravenous (IV) infusion.

Description

Briumvi is a monoclonal antibody that binds to a molecule (CD20) on the surface of immune cells called B cells and depletes (removes) them from circulating in the blood. B cells have several functions including making antibodies, and evidence suggests they play a role in the damage to the brain and spinal cord in MS.

Briumvi is approved by the FDA for the treatment relapsing forms of multiple sclerosis in adults, which include clinically isolated syndrome, relapsing-remitting MS and active secondary progressive MS.

Click to read the Prescribing Information for healthcare professionals.
Click to read the Medication Guide for patients.

Support

Briumvi Patient Support
1-833-274-8684
briumvipatientsupport.com

Financial Assistance Program

Briumvi Patient Support
1-833-274-8684
briumvipatientsupport.com

Infusion Center Resources

Infusion Access Foundation – non-profit advocacy organization that helps patients have greater access to infusion therapies. Visit the site to:

Featured Links: >